Pfizer and CDMOs ramp up Paxlovid manufacturing with Kalamazoo plant expansion leading the way

As the Covid-19 pandemic continues to evolve, pharma companies and manufacturers are exploring how to step up production on antivirals. Pfizer is planning to expand its Kalamazoo-area facility to increase manufacturing capabilities for the oral Covid-19 antiviral Paxlovid, according to a report from Michigan-based news site MLive. The expansion of…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.


*